U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $114.00 Average Target Price from Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH) has been given a consensus recommendation of “Buy” by the five research firms that are currently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $114.00.

Several brokerages have recently commented on USPH. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd.

Insider Activity

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total value of $113,355.84. Following the sale, the director now owns 1,112 shares of the company’s stock, valued at $107,552.64. This trade represents a 51.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,412 shares of company stock valued at $706,605. 1.70% of the stock is currently owned by insiders.

Institutional Trading of U.S. Physical Therapy

Several large investors have recently modified their holdings of USPH. Precision Wealth Strategies LLC boosted its holdings in U.S. Physical Therapy by 5.1% in the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock valued at $239,000 after acquiring an additional 137 shares in the last quarter. First Horizon Advisors Inc. lifted its position in shares of U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after purchasing an additional 186 shares during the period. Louisiana State Employees Retirement System boosted its stake in shares of U.S. Physical Therapy by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after purchasing an additional 200 shares in the last quarter. Martin Capital Advisors LLP boosted its stake in shares of U.S. Physical Therapy by 1.6% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after purchasing an additional 201 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in shares of U.S. Physical Therapy during the second quarter valued at about $28,000.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $91.31 on Wednesday. The business has a 50-day simple moving average of $90.80 and a 200 day simple moving average of $89.73. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of 97.14, a PEG ratio of 4.23 and a beta of 1.46. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were paid a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.93%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.